Analytical Data
-
Gene name
FJX1
- Application
-
Alternative Names
FJX1Four-jointed box protein 1; Four-jointed protein homolog
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q86VR8
-
Expression Region
1-437aa
-
AA Sequence
MGRRMRGAAATAGLWLLALGSLLALWGGLLPPRTELPASRPPEDRLPRRPARSGGPAPAPRFPLPPPLAWDARGGSLKTFRALLTLAAGADGPPRQSRSEPRWHVSARQPRPEESAAVHGGVFWSRGLEEQVPPGFSEAQAAAWLEAARGARMVALERGGCGRSSNRLARFADGTRACVRYGINPEQIQGEALSYYLARLLGLQRHVPPLALARVEARGAQWAQVQEELRAAHWTEGSVVSLTRWLPNLTDVVVPAPWRSEDGRLRPLRDAGGELANLSQAELVDLVQWTDLILFDYLTANFDRLVSNLFSLQWDPRVMQRATSNLHRGPGGALVFLDNEAGLVHGYRVAGMWDKYNEPLLQSVCVFRERTARRVLELHRGQDAAARLLRLYRRHEPRFPELAALADPHAQLLQRRLDFLAKHILHCKAKYGRRSGT
-
Molecular Weight
74.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The FJX1 protein, also known as "Fajans-Jhumka protein 1," has drawn increasing attention in the field of molecular biology due to its potential involvement in cellular processes such as stress response, apoptosis, and DNA repair. Discovered as a member of a novel protein family, FJX1 exhibits unique structural features that may suggest its role in maintaining cellular homeostasis. Studies indicate that FJX1 is expressed in various tissues, implying a versatile function in different cellular contexts. Abnormal expression levels of FJX1 have been linked to several diseases, including cancer, highlighting its significance in disease pathology and potential as a therapeutic target. The investigation of FJX1’s functional mechanisms, interaction partners, and regulatory pathways is crucial for understanding its roles in health and disease. Furthermore, recombinant FJX1 protein production facilitates in-depth studies of its biological functions, paving the way for novel therapeutic strategies and biomarker development. As researchers continue to unravel the complexities of FJX1, its potential implications in diagnostics and therapeutics could significantly advance our understanding of cellular biology and disease management.
